Sponsor
Emercell SAS
36 Chemin De L Hopital, 34270, France
About the sponsor
Clinical research is centred on relapsed/refractory diffuse large B-cell lymphoma, with a focus on disease settings where treatment options are limited and immune-based strategies are of particular interest.
- Diffuse large B-cell lymphoma
- Relapsed/refractory lymphoma
- B-cell malignancy
The sponsor’s activity reflects a concentrated interest in oncology and the treatment of aggressive lymphoid cancers.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.